major
recent
emerg
infecti
diseas
human
due
crossspeci
pathogen
transmiss
anim
establish
product
infect
new
host
speci
virus
must
overcom
barrier
replic
mediat
divers
rapidli
evolv
host
restrict
factor
protein
kinas
r
pkr
mani
viral
antagonist
restrict
factor
speci
specif
exampl
rhesu
cytomegaloviru
pkr
antagonist
inhibit
pkr
african
green
monkey
agm
cell
inhibit
human
rhesu
macaqu
pkr
model
evolutionari
chang
necessari
crossspeci
transmiss
gener
recombin
vaccinia
viru
express
strain
lack
pkr
inhibitor
serial
passag
minimallypermiss
agm
cell
increas
viral
replic
notabl
adapt
agm
cell
also
improv
viru
replic
human
rhesu
cell
genet
analys
includ
deep
sequenc
reveal
amplif
locu
adapt
virus
suppli
addit
tran
confirm
amplif
alon
suffici
improv
replic
virus
amplifi
complet
block
agm
pkr
partial
block
human
pkr
consist
replic
properti
virus
agm
human
cell
final
contrast
agmadapt
virus
could
serial
propag
human
cell
yield
progeni
viru
three
passag
human
cell
thu
amplif
minim
permiss
intermedi
host
necessari
step
enabl
expans
viru
rang
previous
nonpermiss
host
data
support
hypothesi
amplif
weak
viral
antagonist
may
gener
evolutionari
mechan
permit
replic
otherwis
resist
host
speci
provid
molecular
foothold
could
enabl
adapt
necessari
effici
replic
new
host
least
describ
zoonot
microbi
pathogen
capabl
human
human
transmiss
recent
viral
zoonos
led
devast
medic
relev
outbreak
modern
histori
includ
sar
coronaviru
pandem
influenza
hivaid
highlight
urgent
need
understand
virus
adapt
infect
new
speci
popul
level
factor
influenc
transmiss
zoonot
pathogen
human
includ
increas
popul
densiti
greater
contact
wildlif
increas
travel
poor
public
health
infrastructur
howev
factor
allow
microb
increas
access
new
host
directli
enabl
adapt
replic
new
speci
intermedi
host
anim
natur
host
viru
still
permiss
semipermiss
viral
replic
play
critic
role
crossspeci
transmiss
host
facilit
increas
contact
viru
new
host
drive
adapt
chang
may
improv
viru
replic
review
exampl
spillov
nipah
viru
fruit
bat
pig
intermedi
host
increas
human
exposur
viru
result
eventu
human
outbreak
malaysia
anoth
exampl
lentivir
adapt
intermedi
chimpanze
host
led
increas
contact
human
adapt
genet
chang
permit
viru
inhibit
human
version
sever
host
restrict
factor
review
molecular
level
initi
success
viru
entri
new
host
cell
depend
abil
overcom
cellular
host
restrict
factor
subset
protein
inhibit
specif
viru
famili
restrict
retrovirus
mediat
howev
restrict
factor
includ
protein
kinas
r
pkr
block
replic
multipl
viru
famili
pkr
activ
bind
doublestrand
rna
dsrna
common
byproduct
rna
dna
viru
replic
follow
dimer
autophosphoryl
activ
pkr
phosphoryl
asubunit
eukaryot
initi
factor
ultim
arrest
translat
initi
respons
broad
potent
barrier
viral
infect
impos
pkr
viru
famili
evolv
least
one
mechan
inhibit
pkr
pathway
conflict
host
restrict
factor
viral
antagonist
result
arm
race
lead
rapid
evolut
set
gene
extraordinarili
high
rate
posit
select
dnd
among
primat
pkr
gene
reflect
evolutionari
pressur
pkr
evad
viru
antagonist
product
infect
new
host
speci
viru
antagonist
must
rapidli
adapt
escap
differ
pkr
current
studi
model
process
viral
adapt
intermedi
minim
permiss
host
experiment
evolv
recombin
vaccinia
viru
express
rhesu
cytomegaloviru
pkr
antagonist
african
green
monkey
cell
express
pkr
demonstr
amplif
exogen
locu
earli
adapt
suffici
rescu
viru
replic
minimallypermiss
agm
cell
amplif
locu
also
suffici
expand
speci
tropism
virus
enabl
infect
human
rhesu
cell
substanti
better
initi
viru
importantli
amplif
occur
initi
viru
passag
human
fibroblast
suggest
amplif
agm
cell
necessari
intermedi
step
expand
viru
host
rang
gene
amplif
univers
mechan
rapid
adapt
occur
eukaryot
prokaryot
virus
enabl
divers
adapt
includ
evas
host
restrict
factor
review
result
suggest
gene
amplif
intermedi
host
may
risk
factor
broad
crossspeci
transmiss
independ
adapt
event
rhesu
cytomegaloviru
rhcmv
pkr
inhibitor
block
pkr
activ
rescu
replic
vaccinia
viru
mutant
lack
pkr
inhibitor
sever
african
green
monkey
chlorocebu
aethiop
agm
cell
line
howev
discov
recombin
vaccinia
viru
express
lack
known
vaccinia
pkr
antagonist
produc
less
viru
agmderiv
cell
rel
vvbg
contain
although
replic
almost
effici
vvbg
agmderiv
cell
fig
thu
vari
abil
support
vvdedk
replic
differ
agm
cell
spread
microb
anim
human
respons
recent
emerg
human
infecti
diseas
includ
aid
bird
flu
sar
therefor
understand
evolutionari
molecular
mechan
underli
crossspeci
transmiss
critic
import
public
health
enter
new
host
cell
success
viru
depend
abil
overcom
antivir
factor
cell
protein
kinas
r
pkr
investig
process
viru
transmiss
speci
employ
recombin
vaccinia
viru
express
rhesu
cytomegaloviru
pkr
antagonist
protein
inhibit
african
green
monkey
agm
pkr
howev
inhibit
human
rhesu
variant
pkr
serial
passag
agm
cell
result
duplic
viral
genom
improv
replic
agm
cell
remark
duplic
also
enhanc
viru
replic
human
rhesu
cell
contrast
passag
human
cell
without
prior
adapt
agm
cell
improv
replic
result
support
hypothesi
amplif
weak
viral
antagonist
host
defens
protein
one
speci
may
enabl
crossspeci
transmiss
new
host
nonpermiss
initi
viru
replic
defect
cell
may
due
incomplet
inhibit
pkr
cell
test
hypothesi
gener
cell
stabli
express
either
pkrspecif
shrna
kd
result
reduct
pkr
express
scrambl
control
shrna
kd
fig
similarli
pkrspecif
rtqpcr
demonstr
reduct
pkr
mrna
kd
cell
rel
kd
cell
copi
copi
pkrng
total
rna
respect
littl
differ
kd
cell
pkr
level
fig
kd
cell
replic
almost
complet
rescu
vvbg
level
fig
detect
similar
increas
replic
transient
transfect
cell
sirna
specif
pkr
control
sirna
data
shown
sequenc
analysi
pkr
identifi
three
nonsynonym
mutat
rel
previous
report
agm
pkr
genbank
sensit
fig
interestingli
one
singl
nucleotid
variant
heterozyg
cell
chang
residu
evolv
posit
select
primat
although
addit
studi
need
determin
whether
one
pkr
polymorph
respons
increas
resist
result
shown
fig
demonstr
block
replic
cell
mediat
pkr
determin
whether
could
adapt
overcom
pkrmediat
block
replic
cell
util
system
experiment
evolut
infect
cell
low
multipl
infect
moi
hour
post
infect
hpi
lyse
infect
cell
titer
result
viru
infect
new
cell
repeat
cycl
multipl
time
four
passag
observ
increas
viral
replic
remain
stabl
least
three
subsequ
passag
three
independ
lineag
fig
next
perform
competit
assay
assess
rel
fit
passag
viru
comparison
initi
viru
coinfect
cell
either
vva
express
egfp
competitor
express
bgal
moi
viru
viru
produc
hpi
titer
permiss
cell
specif
progeni
virus
enumer
detect
bgal
egfp
vva
express
plaqu
fig
replic
better
wherea
vva
replic
better
confirm
serial
passag
cell
increas
fit
passag
virus
approxim
rel
initi
vvdedk
sinc
passag
virus
replic
effici
minim
permiss
cell
line
investig
abil
passag
virus
replic
primari
cell
diverg
primat
shown
inhibit
human
rhesu
pkr
context
determin
whether
adapt
evolv
serial
passag
cell
affect
viru
speci
tropism
infect
primari
human
foreskin
fibroblast
hff
primari
rhesu
fibroblast
rf
three
passag
viru
pool
vvbg
moi
fig
expect
replic
poorli
vvbg
replic
effici
cell
type
remark
three
passag
pool
replic
better
hff
fig
center
rf
fig
right
pfu
vva
vvb
vvc
use
infect
cell
pfu
progeni
emerg
hff
emerg
rf
respect
suggest
virus
suffici
well
adapt
enabl
continu
propag
cell
see
howev
viru
pool
still
replic
better
either
human
rhesu
cell
fig
left
thu
adapt
minim
permiss
agm
fibroblast
also
provid
substanti
replic
benefit
human
rhesu
cell
express
distantli
relat
pkr
protein
elucid
underli
mechan
gain
fit
harvest
dna
passag
virus
genet
analys
passag
virus
gener
viral
stock
biochem
infect
analys
gene
amplif
mechan
rapid
adapt
vaccinia
viru
well
document
determin
whether
gene
amplif
could
account
broadli
improv
replic
passag
perform
pairedend
illumina
base
deep
sequenc
short
read
archiv
base
read
depth
detect
duplic
locu
three
passag
viru
pool
fig
passag
pool
contain
copi
per
genom
although
number
reflect
averag
heterogen
popul
viral
genom
confirm
estim
copi
number
frequenc
read
detect
recombin
site
near
locu
increas
percentag
total
read
virus
predict
copi
fig
use
pcr
confirm
locu
amplifi
use
extern
direct
primer
specif
amplifi
product
tandem
duplic
gene
fig
detect
kb
product
three
viru
pool
kb
kb
product
vva
viru
pool
fig
unabl
obtain
enough
kb
band
analysi
character
kb
kb
product
sanger
sequenc
larger
product
ident
three
passag
viru
pool
repres
recombin
vaccinia
viru
gene
upstream
downstream
smaller
product
recombin
neor
gene
introduc
select
marker
construct
fig
two
site
repres
predomin
recombin
site
respect
identifi
illumina
deep
sequenc
howev
found
addit
minor
recombin
site
illumina
deep
sequenc
includ
kb
duplic
vvb
presenc
ident
recombin
site
three
passag
viru
pool
suggest
duplic
may
present
low
frequenc
initi
viru
popul
even
though
detect
illumina
sequenc
data
regardless
taken
togeth
data
demonstr
copi
number
viral
genom
substanti
increas
passag
cell
unlik
previou
studi
identifi
adapt
point
mutat
aris
locu
expans
detect
point
indel
mutat
passag
viru
pool
howev
identifi
vaccinia
viru
gene
mutat
present
greater
frequenc
least
one
pool
tabl
three
passag
pool
one
four
differ
singl
nucleotid
delet
within
gene
frequenc
rang
transit
mutat
affect
gene
present
frequenc
vva
vvb
respect
rare
absent
viral
pool
none
mutat
detect
three
pool
occur
frequenc
pool
unlik
account
improv
replic
passag
virus
howev
presenc
vv
gene
mutat
rais
question
whether
expand
speci
tropism
observ
due
vv
gene
mutat
amplif
amplif
alon
suffici
observ
increas
fit
reason
overexpress
tran
might
rescu
replic
investig
possibl
stabli
transduc
hff
confirm
express
immunoblot
data
shown
also
prepar
control
cell
line
hfflhcx
transduc
empti
vector
lhcx
hff
control
cell
replic
approxim
less
effici
vvbg
fig
vvdedk
replic
increas
thu
combin
express
gene
cell
infect
viru
potenti
replic
support
hypothesi
amplif
alon
suffici
expand
speci
tropism
although
amplif
provid
substanti
growth
benefit
hff
rf
passag
virus
still
replic
less
effici
vvbg
fig
determin
whether
incomplet
rescu
hff
due
incomplet
pkr
inhibit
repres
second
block
replic
infect
hff
stabli
transduc
either
pkr
specif
shrna
hffpkr
kd
reduc
pkr
express
nonspecif
shrna
hffctrl
kd
knock
pkr
increas
replic
indic
pkr
major
barrier
replic
cell
fig
three
passag
viru
pool
replic
better
hffpkr
kd
cell
hffctrl
kd
cell
suggest
amplif
fulli
inhibit
pkr
partial
inhibit
human
pkr
howev
virus
replic
less
well
vvbg
hffpkr
kd
cell
remain
replic
defect
may
due
incomplet
pkr
knockdown
cell
although
also
possibl
addit
host
factor
inhibit
replic
hff
unlik
mani
known
pkr
inhibitor
block
pkr
phosphoryl
inhibit
pkr
pathway
pkr
phosphoryl
prior
phosphoryl
howev
possibl
amplif
inhibit
pkr
altern
mechan
dsrna
sequestr
determin
whether
amplif
alter
mechan
pkr
inhibit
infect
vvbg
vva
moi
collect
cell
lysat
hpi
metabol
label
demonstr
express
vaccinia
viru
protein
cell
though
much
lower
quantiti
vvbg
consist
former
viru
unabl
inhibit
pkr
complet
fig
top
left
panel
contrast
vva
produc
abund
vaccinia
viru
protein
similar
vvbg
confirm
viru
effici
inhibit
pkr
pathway
use
immunoblot
analys
determin
stage
pkr
pathway
inhibit
viru
fig
lower
panel
express
notic
higher
vva
infect
cell
compar
infect
consist
better
replic
vva
cell
fig
lane
pkr
phosphoryl
elev
viru
infect
cell
except
vvbg
consist
previou
report
even
block
pkr
pathway
block
pkr
autophosphoryl
fig
lane
level
infect
cell
intermedi
mock
infect
cell
suggest
singl
gene
weakli
inhibit
pkr
pathway
fig
lane
infect
vva
result
low
level
phosphoryl
similar
detect
vvbg
infect
cell
fig
compar
lane
indic
amplif
suffici
complet
inhibit
pkrmediat
translat
shutdown
stage
pkr
phosphoryl
togeth
data
suggest
pkrmediat
pressur
cell
select
rapid
amplif
locu
amplif
suffici
enabl
viru
block
pkrmediat
defens
cell
without
alter
mechan
pkr
inhibit
previou
studi
alon
insuffici
inhibit
human
pkr
howev
passag
virus
report
replic
substanti
better
hff
suggest
amplif
abl
inhibit
pkr
least
partial
cell
test
hypothesi
determin
whether
mechan
pkr
inhibit
hff
infect
hff
moi
prepar
cell
lysat
hpi
contrast
infect
cell
infect
hff
result
nearli
complet
shut
protein
synthesi
hpi
fig
top
right
panel
produc
trace
amount
compar
vva
infect
hff
result
detect
though
still
low
overal
level
label
protein
much
fig
lane
pkr
phosphoryl
phosphoryl
elev
infect
vva
compar
mock
vvbg
control
fig
compar
lane
lane
data
suggest
singl
copi
insuffici
inhibit
translat
shutoff
mediat
human
pkr
amplif
weak
antagonist
result
partial
inhibit
human
pkr
allow
enough
protein
synthesi
support
modest
level
viru
replic
select
agm
cell
result
broad
expans
viral
speci
tropism
investig
whether
passag
directli
hff
would
similarli
select
mutant
amplif
improv
replic
hff
therefor
serial
infect
cell
hff
parallel
fig
cell
viral
fit
increas
four
passag
contrast
viru
replic
strongli
inhibit
hff
unabl
detect
viral
replic
three
round
infect
three
pool
data
suggest
experiment
condit
adapt
cell
necessari
intermedi
step
improv
replic
hff
final
evalu
whether
improv
replic
virus
passag
cell
suffici
enabl
stabl
propag
hff
therefor
serial
infect
hff
vva
vvb
vvc
low
multipl
infect
moi
passag
abl
propag
virus
hff
least
four
passag
moreov
replic
increas
two
passag
suggest
adapt
occur
hff
cell
fig
defin
mutat
may
evolv
serial
passag
hff
perform
pairedend
illumina
base
deep
sequenc
viral
dna
isol
fourth
round
passag
hff
find
mutat
howev
detect
averag
copi
number
viru
pool
deriv
vva
vvb
vvc
respect
repres
averag
expans
locu
approxim
one
addit
copi
rel
virus
addit
two
vv
gene
mutat
indel
aros
adapt
lost
hff
adapt
two
new
mutat
missens
uncertain
signific
appear
hff
adapt
tabl
taken
togeth
studi
suggest
hypothesi
gene
amplif
act
broadli
increas
replic
varieti
host
may
provid
molecular
foothold
allow
continu
speciesspecif
adapt
viru
resist
host
crossspeci
pathogen
transmiss
respons
emerg
infecti
diseas
human
past
year
human
immunodefici
virus
avian
influenza
virus
recent
describ
middl
east
respiratori
syndrom
coronaviru
exemplifi
ongo
threat
potenti
anim
virus
spread
among
human
highlight
urgent
need
understand
mechan
underli
crossspeci
transmiss
adapt
new
host
one
mechan
genet
locu
amplif
respons
select
pressur
observ
virus
bacteria
demonstr
amplif
exogen
gene
suffici
block
potent
pkrmediat
inhibit
improv
replic
agmderiv
cell
adapt
also
expand
speci
tropism
viru
enabl
markedli
improv
replic
otherwis
resist
human
rhesu
monkey
cell
importantli
fail
replic
hff
level
suffici
sustain
transmiss
upon
serial
passag
demonstr
adapt
critic
intermedi
step
expand
viral
speci
tropism
thu
process
adapt
one
host
may
increas
likelihood
viru
transmiss
varieti
diverg
speci
pkrmediat
select
pressur
locu
amplifi
serial
passag
minim
permiss
cell
fig
clear
whether
initi
duplic
occur
prepar
stock
cell
first
passag
cell
observ
faint
pcr
product
start
viru
use
outward
direct
primer
one
three
experi
fig
detect
ident
recombin
break
point
independ
passag
viru
pool
suggest
amplif
may
present
low
level
start
viru
howev
amplif
locu
occur
level
illumina
deep
sequenc
detect
fig
support
idea
duplic
present
rare
initi
stock
addit
detect
recombin
neor
fig
vva
pool
suggest
recombin
event
aris
serial
passag
regardless
aros
amplif
locu
substanti
enrich
viru
passag
select
pressur
fig
previou
studi
demonstr
amplif
adapt
mechan
human
pkr
strikingli
similar
kinet
current
studi
togeth
two
studi
support
hypothesi
preexist
frequent
aris
de
novo
gene
duplic
enabl
vaccinia
viru
adapt
rapidli
select
condit
impos
rel
resist
host
restrict
factor
accordion
hypothesi
rapid
evolut
posit
gene
amplif
provid
replic
benefit
viru
extra
copi
weak
viral
antagonist
host
defens
provid
addit
templat
acquir
potenti
adapt
mutat
inde
eld
et
al
detect
adapt
mutat
appar
aris
amplif
locu
therefor
surpris
mutat
aros
although
may
addit
round
replic
would
reveal
mutat
howev
detect
mutat
endogen
vaccinia
viru
gene
occur
frequenc
fig
data
suggest
none
mutat
necessari
expand
speci
tropism
fig
rule
possibl
may
provid
replic
benefit
presenc
mutat
intrigu
either
present
frequenc
one
pool
detect
three
pool
none
gene
previous
implic
pkr
antagonist
conserv
across
multipl
poxviru
famili
http
wwwpoxvirusorg
function
unknown
subunit
rna
polymeras
mutat
identifi
act
like
report
rna
polymeras
mutat
decreas
transcript
elong
mutat
might
result
less
dsrna
product
therefor
less
pkr
activ
gene
unknown
biochem
function
may
involv
evas
adapt
immun
respons
three
passag
viru
pool
contain
nucleotid
delet
greater
frequenc
ortholog
conserv
across
poxvirus
intriguingli
variola
viru
contain
truncat
consist
previou
studi
agm
cell
type
pkr
phosphoryl
cell
infect
vva
thu
improv
replic
passag
viru
pool
cell
like
due
enhanc
basic
inhibit
pkr
due
anoth
mechan
dsrna
sequestr
reduct
abund
dsrna
infect
cell
level
lower
found
infect
cell
fig
lane
suggest
even
singl
copi
abl
inhibit
pkr
function
small
degre
amplif
locu
appear
need
express
enough
inhibit
phosphoryl
potent
enabl
effici
viral
replic
also
possibl
elev
express
necessari
block
anoth
activ
pkr
autophagi
inflammasom
respons
might
aid
replic
adapt
cell
provid
substanti
replic
advantag
human
rhesu
monkey
fibroblast
although
vva
replic
much
higher
titer
express
hff
metabol
label
reveal
rel
low
protein
synthesi
rate
phosphoryl
still
elev
vva
infect
compar
vvbg
substanti
proport
block
vva
replic
hff
still
mediat
pkr
despit
overexpress
fig
suggest
adapt
hff
may
necessari
block
pkr
pathway
hff
complet
result
indic
overexpress
block
human
pkr
incomplet
nonetheless
virus
adapt
initi
passag
replic
hff
level
suffici
enabl
sustain
passag
hff
furthermor
virus
acquir
addit
chang
result
serial
passag
hff
although
biolog
relev
chang
current
unclear
combin
observ
serial
passag
hff
fail
gener
adapt
virus
fig
data
suggest
adapt
minim
permiss
cell
critic
intermedi
step
gener
viru
broaden
speci
tropism
crossspeci
pathogen
transmiss
import
sourc
emerg
infect
worldwid
studi
illustr
gene
amplif
weak
viral
antagonist
pkr
broaden
host
rang
vaccinia
viru
presenc
gene
famili
larg
dna
virus
eg
cytomegaloviru
famili
member
provid
indirect
evid
episod
locu
amplif
also
occur
virus
adapt
viral
antagonist
nonsynonym
mutat
potenti
confer
speciesspecif
advantag
viru
specif
host
contrast
gene
amplif
subsequ
overexpress
antagonist
like
increas
protein
activ
mass
action
effect
varieti
host
thu
gene
amplif
may
common
evolutionari
strategi
employ
larg
dna
virus
permit
modest
replic
otherwis
resist
host
speci
provid
molecular
foothold
enabl
adapt
necessari
effici
replic
spread
new
host
virus
cell
cultur
agm
fibroblast
coriel
institut
medic
research
human
foreskin
fibroblast
hff
rhesu
fibroblast
rf
hela
cell
deriv
cell
line
maintain
dulbecco
modifi
eagl
medium
supplement
nuserum
bd
bioscienc
previous
describ
time
cell
line
also
propag
minim
essenti
medium
fetal
calf
serum
anitbiot
enabl
rapid
growth
cell
transduc
nonsilenc
control
pkrtarget
shrna
lentivir
vector
open
biosystem
catalogu
number
respect
select
puromycin
mgml
gener
kd
kd
cell
construct
move
gene
ctermin
biotinyl
signal
tag
hindiiipmei
fragment
hindiiihpai
site
plhcx
clontech
laboratori
inc
hfflhcx
produc
transduc
hff
retrovir
vector
made
use
lhcx
respect
select
hygromycin
b
mgml
vaccinia
viru
vv
copenhagen
strain
obtain
bertram
jacob
arizona
state
univers
vvbg
propag
titer
cell
construct
replac
gene
vacv
strain
background
provid
bertram
jacob
homolog
recombin
bp
arm
creat
pcr
amplif
dna
primer
bp
arm
creat
pcr
amplif
dna
primer
read
frame
egfp
includ
pest
sequenc
amplifi
primer
use
clonetech
templat
pcr
product
gelpurifi
mix
togeth
templat
fusion
pcr
use
pfuultra
polymeras
agil
technolog
use
pcr
reaction
pcr
product
clone
topo
vector
gener
plasmid
use
templat
pcr
amplif
marker
arm
use
follow
gelpurif
cell
grown
well
plate
infect
moi
transfect
hour
infect
mg
purifi
pcr
product
cell
lysat
collect
hour
plate
dilut
seri
cell
green
plaqu
pick
hour
highest
dilut
possibl
plaqu
purifi
addit
three
time
cell
egfp
express
control
endogen
promot
vvdedk
propag
titer
use
cell
construct
homolog
recombin
plasmid
thymidin
kinas
tk
locu
vvdedk
recombin
viru
plaqu
purifi
three
time
select
subsequ
propag
titer
cell
total
rna
cell
amplifi
use
previous
report
pkr
specif
primer
amplif
product
gel
purifi
clone
use
strataclon
pcr
clone
kit
agil
multipl
plasmid
submit
sanger
sequenc
use
pkr
specif
sequenc
primer
contig
assembl
curat
geneiou
pro
genbank
predict
amino
acid
sequenc
align
predict
amino
acid
sequenc
previous
report
agm
genbank
rhesu
macaqu
genbank
human
pkr
genbank
use
http
wwwchembnetorgsoftwareclustalwhtml
everi
round
infect
triplic
confluent
cm
dish
figur
plate
figur
hff
infect
moi
two
day
postinfect
cell
collect
pellet
resuspend
ml
nuserum
three
freezethaw
cycl
viru
titer
determin
plaqu
assay
use
next
round
infect
insuffici
viru
produc
infect
cell
moi
entir
volum
viru
lysat
use
subsequ
round
infect
vaccinia
viru
dna
passag
figur
passag
hff
figur
right
virus
purifi
infect
cell
cytoplasm
extract
genet
analys
describ
passag
pool
expand
passag
use
virolog
assay
cell
coinfect
moi
either
vva
moi
common
competitor
two
day
postinfect
cell
collect
pellet
resuspend
ml
nuserum
three
freezethaw
cycl
viru
titer
determin
plaqu
assay
plaqu
detect
bgal
substrat
imagen
red
c
rg
follow
manufactur
direct
life
technolog
plaqu
imag
typhoon
trio
imag
egfp
nm
excit
bp
filter
imagen
red
nm
excit
bp
filter
mmpixel
resolut
classifi
gfp
imagen
red
doubl
posit
use
imagej
softwar
http
rsbinfonihgovij
extern
direct
pcr
extern
direct
oligonucleotid
design
bind
near
end
highfidel
pcr
perform
ng
purifi
viru
dna
follow
manufactur
direct
phusion
thermo
scientif
reaction
puls
follow
cycl
min
amplif
product
gelpurifi
clone
use
strataclon
pcr
clone
kit
agil
follow
manufactur
suggest
protocol
recombin
site
identifi
sanger
sequenc
product
librari
prepar
sequenc
viral
pool
ng
viral
dna
shear
ligat
adaptor
transposit
use
nextera
kit
epicentr
follow
manufactur
direct
sever
modif
transposit
perform
ul
volum
use
ml
nextera
transposas
enzym
hmw
reaction
buffer
final
transposit
carri
minut
shear
adaptorlig
templat
transfer
directli
pcr
reaction
amplif
addit
pcr
incorpor
samplespecif
barcod
tag
revers
primer
amplifi
librari
pool
clean
use
ampur
bead
beckman
coulter
ratio
bead
input
pool
librari
sequenc
illumina
hiseq
instrument
illumina
use
forward
revers
read
index
read
persampl
barcod
sequenc
analysi
de
novo
assembl
guid
vaccinia
viru
copenhagen
genom
genbank
use
construct
refer
assembl
sequenc
tabl
shotgun
read
parent
viru
assembl
contig
use
abyss
parent
viru
read
realign
result
assembl
contig
use
bwa
discrep
read
contig
reflect
de
novo
assembl
error
correct
contig
follow
manual
examin
contig
order
concaten
comparison
copenhagen
sequenc
read
evolv
viral
pool
align
parent
refer
genom
singlebas
shortindel
variant
call
use
genom
analysi
toolkit
custom
script
use
determin
allel
frequenc
fraction
read
support
variant
allel
align
read
given
site
variant
found
sampl
copi
number
estim
count
depth
read
coverag
within
slide
window
bp
correct
effect
differ
gc
composit
divid
parent
strain
read
depth
evert
read
duplic
breakpoint
identifi
use
bwasw
custom
script
previous
describ
cell
mock
infect
infect
vaccinia
virus
moi
one
day
postinfect
cell
lyse
sodium
dodecyl
sulfat
sd
equival
amount
lysat
separ
sdspolyacrylamid
gel
transfer
polyvinyliden
difluorid
pvdf
membran
probe
one
follow
antibodi
pkr
santa
cruz
biotechnolog
inc
phosphopkr
epitom
antibodi
cell
signal
technolog
catalog
number
respect
actin
sigma
purchas
antibodi
use
accord
manufactur
recommend
protein
detect
use
western
star
chemiluminesc
detect
system
appli
biosystem
accord
manufactur
recommend
densitometri
measur
perform
use
imagej
total
rna
extract
kd
kd
cell
trizol
reagent
follow
manufactur
protocol
invitrogen
ng
total
rna
assay
per
reaction
standard
curv
gener
serial
dilut
pkr
contain
plasmid
describ
pkr
sequenc
analysi
dilut
pgml
salmon
sperm
dna
sampl
amplifi
triplic
use
gotaq
rtqpcr
kit
follow
manufactur
protocol
promega
use
pkr
specif
primer
rtqpcr
perform
rotorgen
q
thermocycl
qiagen
temperatur
hold
min
min
follow
cycl
raw
data
analyz
use
includ
rotorgen
q
seri
softwar
use
automat
cycl
threshold
ct
set
assign
baselin
threshold
ct
determin
nonlinear
regress
analysi
determin
pkr
copi
number
experiment
sampl
perform
graphpad
prism
sd
equival
amount
protein
sampl
separ
sdspolyacrylamid
gel
dri
visual
autoradiographi
figur
rtqpcr
analysi
pkr
copi
number
cell
line
rtqpcr
perform
serial
dilut
pkr
contain
plasmid
copi
pkr
gener
standard
curv
top
data
repres
mean
confid
interv
pkr
copi
numberng
total
rna
interpol
standard
curv
kd
kd
cell
bottom
rel
cell
kd
cell
express
slightli
less
pkr
decreas
kd
cell
decreas
pkr
express
similarli
kd
cell
express
less
pkr
pkrctrl
kd
cell
consist
fig
tif
figur
amino
acid
align
african
green
monkey
human
rhesu
pkr
predict
pkr
amino
acid
sequenc
agm
rhesu
macaqu
genbank
human
genbank
align
use
clustal
w
identifi
three
nonsynonym
amino
acid
differ
grey
green
highlight
residu
two
agm
allel
one
differ
site
evolv
posit
select
primat
green
highlight
residu
rel
pkr
rhesu
human
pkr
ident
amino
acid
level
respect
tif
figur
increas
fit
vva
compar
assess
indirect
competit
assay
cell
coinfect
either
vva
moi
competitor
viru
moi
two
day
postinfect
viral
progeni
collect
titer
cell
repres
typhoon
imag
viru
titer
plate
produc
infect
combin
either
top
panel
vva
bottom
panel
b
plaqu
score
egfp
express
vva
bgal
express
doubl
describ
materi
method
vva
replic
better
vvdedk
rel
data
repres
mean
sd
tif
figur
predomin
recombin
site
identifi
locu
amplif
schemat
extern
direct
pcr
extern
direct
oligonucleotid
grey
arrow
design
bind
end
white
tandem
duplic
produc
amplif
product
b
extern
direct
pcr
reveal
enrich
amplif
product
passag
viru
pool
c
schemat
initi
locu
top
predomin
recombin
site
identifi
three
passag
virus
middl
vva
alon
bottom
vaccinia
viru
gene
color
green
blue
exogen
sequenc
color
dark
red
brown
neor
pcr
product
amplifi
extern
direct
primer
black
bar
duplic
sequenc
grey
box
recombin
site
red
arrowhead
indic
recombin
site
occur
middl
nt
nt
rel
refer
vaccinia
viru
copenhagen
strain
genbank
bottom
nt
nt
neor
invitrogen
tif
